AAN 2026: Crexont linked to more on time in new Parkinson’s study
WHY IT MATTERS
If you take levodopa for Parkinson's and struggle with 'off' periods when symptoms return between doses, Crexont may offer a way to extend your good symptom control time throughout the day.
Researchers found that a Parkinson's disease medication called Crexont helped patients spend more time feeling better and less time experiencing symptoms when they switched from other levodopa treatments. The study showed improvements in movement control and daily functioning across different patient groups. This is early-stage research being presented at a medical conference.
People with Parkinson’s disease who switch from other formulations of levodopa to Crexont may experience improvements in daily symptom control, according to new data from an ongoing clinical trial. “Crexont substantially increased [good on] time, reduced [off time], and improved motor function in [Parkinson’s] patients across all therapy groups, confirming that switching patients from other […] The post AAN 2026: Crexont linked to more on time in new Parkinson’s study app
ASK YOUR DOCTOR
Ask your neurologist at your next appointment whether switching to Crexont might be appropriate for you, especially if you experience significant off-time periods.